Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7898756rdf:typepubmed:Citationlld:pubmed
pubmed-article:7898756lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C0019564lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C0006685lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C1521797lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:7898756lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:7898756pubmed:issue1-2lld:pubmed
pubmed-article:7898756pubmed:dateCreated1995-4-27lld:pubmed
pubmed-article:7898756pubmed:abstractTextEffects of Ca2+ channel blockers on GABAergic transmission were examined with rat cultured hippocampal neurons. The GABAergic synaptic currents (IPSCs) evoked by electrical stimulation of single presynaptic neurons were recorded from voltage-clamped postsynaptic neurons. The amplitude of IPSCs was not changed by 10 microM nifedipine (L-type Ca2+ channel blocker), but was decreased irreversibly to 37% of control by 1 microM omega-conotoxin GVIA (N-type blocker, CgTX), to 67% by 0.1 microM omega-agatoxin IVA (P-type blocker, AGTX), and to 1% by both toxins. From these data and the Ca(2+)-dependence of IPSCs, the contributions of CgTX-sensitive and AGTX-sensitive Ca2+ channels to the transmission were estimated at 59% and 36%, respectively.lld:pubmed
pubmed-article:7898756pubmed:languageenglld:pubmed
pubmed-article:7898756pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:citationSubsetIMlld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7898756pubmed:statusMEDLINElld:pubmed
pubmed-article:7898756pubmed:monthNovlld:pubmed
pubmed-article:7898756pubmed:issn0304-3940lld:pubmed
pubmed-article:7898756pubmed:authorpubmed-author:YamamotoCClld:pubmed
pubmed-article:7898756pubmed:authorpubmed-author:HirataKKlld:pubmed
pubmed-article:7898756pubmed:authorpubmed-author:SawadaSSlld:pubmed
pubmed-article:7898756pubmed:authorpubmed-author:Ohno-ShosakuT...lld:pubmed
pubmed-article:7898756pubmed:issnTypePrintlld:pubmed
pubmed-article:7898756pubmed:day7lld:pubmed
pubmed-article:7898756pubmed:volume181lld:pubmed
pubmed-article:7898756pubmed:ownerNLMlld:pubmed
pubmed-article:7898756pubmed:authorsCompleteYlld:pubmed
pubmed-article:7898756pubmed:pagination145-8lld:pubmed
pubmed-article:7898756pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:meshHeadingpubmed-meshheading:7898756-...lld:pubmed
pubmed-article:7898756pubmed:year1994lld:pubmed
pubmed-article:7898756pubmed:articleTitleContributions of multiple calcium channel types to GABAergic transmission in rat cultured hippocampal neurons.lld:pubmed
pubmed-article:7898756pubmed:affiliationDepartment of Physiology, Faculty of Medicine, Kanazawa University, Ishikawa, Japan.lld:pubmed
pubmed-article:7898756pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7898756pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7898756lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7898756lld:pubmed